-transparent.png){kind=logo}
The effects of compounds with tumor promoting activity (mezerein, teleocidin and palytoxin) on rat growth hormone (rGH) release was compared to that of TPA (12-O-tetradecanoyl phorbol-13-acetate). Mezerein and teleocidin both of which are activators of protein kinase C (TPA type tumor promoter), elicited rGH release about 3.5 to 4 fold above control values. The ED 50 was 16 nM for mezerein, 1.1 nM for teleocidin and 1.5 nM for TPA. In contrast to mezerein or teleocidin, a non-TPA type tumor promoter (palytoxin) which does not activate protein kinase C failed to stimulate rGH release. These observations suggest that the activation of protein kinase C is essential in the release of rGH induced by the tumor promoters.
E Ohmura, and
T Tsushima, and
N Emoto, and
E Obuchi, and
K Shizume
August 1989,
Endocrinology,
E Ohmura, and
T Tsushima, and
N Emoto, and
E Obuchi, and
K Shizume
August 1983,
Endocrinology,
E Ohmura, and
T Tsushima, and
N Emoto, and
E Obuchi, and
K Shizume
January 1987,
Advances in cancer research,
E Ohmura, and
T Tsushima, and
N Emoto, and
E Obuchi, and
K Shizume
February 1976,
Endocrinology,
E Ohmura, and
T Tsushima, and
N Emoto, and
E Obuchi, and
K Shizume
February 1984,
Journal of endocrinological investigation,
E Ohmura, and
T Tsushima, and
N Emoto, and
E Obuchi, and
K Shizume
February 2002,
Journal of neuroendocrinology,
E Ohmura, and
T Tsushima, and
N Emoto, and
E Obuchi, and
K Shizume
January 1983,
Princess Takamatsu symposia,
E Ohmura, and
T Tsushima, and
N Emoto, and
E Obuchi, and
K Shizume
May 1996,
Endocrinology,
E Ohmura, and
T Tsushima, and
N Emoto, and
E Obuchi, and
K Shizume
April 1986,
Diabetes,
E Ohmura, and
T Tsushima, and
N Emoto, and
E Obuchi, and
K Shizume
August 1990,
Molecular and cellular endocrinology,
